在ES-SCLCLC的第一线治疗方面,最近的进展和未来的战略
Igor Gomez-Randulfe1, Rita Leporati2, Brinda Gupta3
1Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
European journal of cancer (Oxford, England : 1990)
|February 1, 2024
概括
免疫检查点抑制剂 (ICI) 与化疗相结合,对于扩散阶段小细胞肺癌 (ES-SCLC) 提供适度的益处. 研究继续探索新型药物和生物标志物,以改善患者选择和治疗这种侵袭性疾病的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药理学 药理学是指药理学的学科.
背景情况:
- 扩展阶段小细胞肺癌 (ES-SCLC) 治疗已经通过免疫检查点抑制剂 (ICI) 加上化疗获得了适度的收益.
- 在识别预测生物标志物和开发ES-SCLC更有效的疗法方面,仍然存在重大挑战.
研究的目的:
- 审查目前和新兴的广泛阶段小细胞肺癌的治疗策略.
- 突出有前途的治疗药物和ES-SCLC管理的未来方向.
主要方法:
- 关于ES-SCLC治疗近期进展的文献综述.
- 对新型治疗药物的分析,包括较新的ICI,抗血管生成药物,PARP抑制剂,lurbinectedin和抗DLL3药物.
主要成果:
- 结合ICI和化疗的组合疗法在ES-SCLC结果中显示出适度的改善.
- 几种新型药物和策略正在研究中,显示出未来临床应用的潜力.
结论:
- 尽管有进展,但有效的生物标志物识别和新药开发对于推进ES-SCLC治疗至关重要.
- 未来的方向包括探索新的ICI,抗血管原剂,PARP抑制剂,卢宾丁和抗DLL3疗法.
更多相关视频
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
8.0K
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.4K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K